Daratumumab as maintenance therapy for transplant-eligible patients with NDMM: What have we learned from GRIFFIN and CASSIOPEIA trials?
Multiple Myeloma Hub
00:00
The Impact of Daratumumab Maintenance Therapy on Progression-Free Survival in Multiple Myeloma Patients
This chapter delves into the role of daratumumab in enhancing progression-free survival for multiple myeloma patients after consolidation therapy. It explores key insights from trials like Griffin and Cassiopeia, emphasizing the advantages of ongoing daratumumab treatment and mentions current research efforts in this field.
Transcript
Play full episode
